🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chronic Obstructive Pulmonary Disease Exacerbation

Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure NCT07047092Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Non-invasive Ventilation (NIV), Continous Positive Airway Pressure (CPAP) COPD Exacerbation Follow Up NCT07118306n/a5 sites📍 Park Ridge📍 Cherry Hill📍 Philadelphia Viz.ai, Inc. Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa NCT04427826Phase 1, Phase 21 site📍 Grenoble University Hospital, Grenoble · Tests: Morphine hydrochloride Effects of COPD Standardized Management on COPD Exacerbation NCT04664491NA1 site📍 Beijing China-Japan Friendship Hospital · Tests: Standardized COPD management, Routine COPD management Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project NCT06235502NA1 site📍 Aalborg Aalborg University Hospital · Tests: Home-based cycle-exercise for COPD patients, Standard of Care The CATALINA Study NCT05008081n/a22 sites📍 Linz📍 Vienna📍 Brussels Wim Janssens Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease NCT03450603n/a1 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization NCT07587658Phase 41 site📍 Mullica Hill Regeneron Pharmaceuticals · Tests: dupilumab, Placebo 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation NCT07192016Phase 41 site📍 London Western University, Canada · Tests: fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis NCT06114667NA3 sites📍 Montpellier📍 Nîmes📍 Poitiers University Hospital, Montpellier · Tests: Ventilatory support via nasal high flow, Ventilatory support via NIV Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease NCT06198309n/a1 site📍 Beijing Li An A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD NCT07344285NA1 site📍 Shatin Chinese University of Hong Kong · Tests: Intervention Group, Usual Care Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients NCT06691399NA1 site📍 Asyut Assiut University · Tests: Oral care Interoception and Symptom Perception in Acute COPD Exacerbation NCT07719231n/a1 site📍 Istanbul Saglik Bilimleri Universitesi · Tests: No Intervention: Observational Cohort The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute Exacerbation NCT07762157NA1 site📍 Hong Kong North District Hospital · Tests: Tele-pulmonary rehabilitation High Flow Nasal Oxygen for Exacerbation COPD NCT06084117NA4 sites📍 Delft📍 Rotterdam📍 Rotterdam Franciscus Gasthuis · Tests: HFNO, NIV The London COPD Exacerbation Cohort NCT02755974n/a1 site📍 London Imperial College London The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry NCT07612878n/a7 sites📍 Indianapolis📍 Lawrence📍 Durham Sanofi · Tests: Cohort 1: Dupilumab, Cohort 2: usual care only Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe). NCT06724315n/a1 site📍 São Paulo Hospital Israelita Albert Einstein Exploring How Viral Infections Affect People With Chronic Lung Disease NCT06625944n/a1 site📍 London Imperial College London Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS) NCT05958563NA15 sites📍 Angers📍 Bordeaux📍 Brest University Hospital, Angers · Tests: continuous positive airway pressure treatment Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease NCT07125352n/a1 site📍 Cairo Ain Shams University · Tests: neutrophil lymphocyte ratio in COPD patients Non-contact Proactive Remote Monitoring of COPD Exacerbations NCT05598983n/a1 site📍 London Life Detection Technologies Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations NCT05704881n/a2 sites📍 Grenoble📍 Lyon University Hospital, Grenoble · Tests: End-Tidal CO2 measurement during COPD exacerbation Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness NCT07536035n/a1 site📍 Singapore National University Hospital, Singapore Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) NCT06892210Phase 414 sites📍 Rønne📍 Copenhagen📍 Copenhagen Copenhagen Respiratory Research · Tests: Methylprednisolone (drug), Hydrocortisone Mechanism(s) of Airflow Limitation During Exacerbation of Asthma NCT01225913Phase 41 site📍 Lakewood Gelb, Arthur F., M.D. · Tests: fluticasone/salmeterol in all asthmatics, budesonide/formoterol or fluticasone/salmeterol in all asthmatics Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients NCT03890224NA1 site📍 Paris Clinact · Tests: home ventilators Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial NCT04890938NA2 sites📍 Hamilton📍 Hamilton McMaster University · Tests: Sputum-guided management and comprehensive care management, Usual Care Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital NCT06597331n/a1 site📍 Gothenburg Sahlgrenska University Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy